Phenominer Database Results (42 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Method Notes Clinical Measurement Notes Record ID Study ID
WAG/Nov both adrenal glands wet weight control condition Redina OE, et al., Clin Exp Hypertens. 2010;32(6):364-71. doi: 10.3109/10641961003628502. adrenal gland mass male 180 days 13 41.9 mg 2.6 9.37 post excision weight measurement 0.0 0 97065 1818
WAG/Nov both adrenal glands wet weight to body weight ratio control condition Redina OE, et al., Clin Exp Hypertens. 2010;32(6):364-71. doi: 10.3109/10641961003628502. adrenal gland mass male 180 days 13 16.2 mg/100g 0.8 2.88 post excision weight measurement 0.0 0 97067 1818
WAG/Nov thymus weight to body weight ratio control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymus mass male 150 days-180 days 10 0.79 mg/g 0.17 0.54 post excision weight measurement 0.0 0 107686 3096
WAG/Nov CD4-CD8+ thymocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 74.55 x10E6/organ 18.13 57.33 flow cytometry method 0.0 0 cd4-cd8+ t-cell 107723 3096
WAG/Nov CD11b/c+ splenocyte count to total splenocyte count ratio control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 13.89 % 1.48 4.68 flow cytometry method 0.0 0 cd11b/c+ spleen 107735 3096
WAG/Nov number of head dipping movements in an experimental apparatus control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. head movement trait male 84 days-98 days 6 1.83 null 0.98 2.4 elevated plus maze apparatus method 300.0 0 within elevated plus maze head dips 110714 3182
WAG/Nov amount of time spent making stretched-attend posture movements in an experimental apparatus control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. stationary movement trait male 84 days-98 days 6 28.72 s 10.01 24.52 elevated plus maze apparatus method 300.0 0 stretch attend posture duration 110722 3182
WAG/Nov amount of time spent exploring a familiar object in an experimental apparatus control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. exploratory behavior trait male 84 days-98 days 6 11.8 s 5.53 13.55 open field apparatus method 300.0 0 NOR test; possibly three-chamber assay (MMO:0000604) familiar object exploration duration 110728 3182
WAG/Nov thymocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 894.54 x10E6/organ 216.09 683.34 isolated cell counting method 0.0 0 107692 3096
WAG/Nov plasma 11-dehydrocorticosterone level control condition Cherkasova OP, Bull Exp Biol Med. 2006 Jan;141(1):30-2. doi: 10.1007/s10517-006-0085-4. blood corticosterone amount male 150 days-180 days 6 20.0 ng/ml 3.27 8.0 plasma 11-dehydrocorticosterone analysis 0.0 0 plasma 11-dehydrocorticosterone analysis (MMO:0000748) 107656 3087
WAG/Nov G0 stage diploid thymocyte count to total thymocyte count ratio control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. T cell development trait male 150 days-180 days 10 92.68 % 0.6 1.9 flow cytometry method 0.0 0 107708 3096
WAG/Nov CD11b/c+ splenocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 86.13 x10E6/organ 25.02 79.12 flow cytometry method 0.0 0 cd11b/c+ spleen 107738 3096
WAG/Nov plasma triglyceride level control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. blood triglyceride amount male 150 days-180 days 10 1.25 mmol/l 0.11 0.34 plasma triglyceride analysis 0.0 0 107774 3096
WAG/Nov plasma high density lipoprotein phospholipid level control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. blood HDL phospholipid amount male 150 days-180 days 10 50.5 mg/dl 2.3 7.27 plasma high-density lipoprotein-cholesterol measurement test 0.0 0 107786 3096
WAG/Nov plasma corticosterone level to 11-dehydrocorticosterone level ratio control condition Cherkasova OP, Bull Exp Biol Med. 2006 Jan;141(1):30-2. doi: 10.1007/s10517-006-0085-4. blood corticosterone amount male 150 days-180 days 6 5.05 null 0.43 1.05 plasma corticosterone analysis 0.0 0 plasma corticosterone analysis (MMO:0000745) 107660 3087
WAG/Nov time to first stretched-attend posture movement within an experimental apparatus control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. stationary movement trait male 84 days-98 days 6 20.36 s 5.93 14.53 elevated plus maze apparatus method 300.0 0 stretch attend posture latency 110724 3182
WAG/Nov CD4+CD8- thymocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 199.43 x 10E6/organ 33.75 106.73 flow cytometry method 0.0 0 cd4+cd8- t-cell 107717 3096
WAG/Nov CD4+CD8+ thymocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 512.96 x10E6/organ 161.9 511.97 flow cytometry method 0.0 0 cd4+cd8+ t-cell 107720 3096
WAG/Nov CD4+CD25- splenocyte count to total splenocyte count ratio control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 25.7 % 1.16 3.67 flow cytometry method 0.0 0 cd4+cd25- spleen 107729 3096
WAG/Nov CD3+ splenocyte count to total splenocyte count ratio control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 29.81 % 0.57 1.8 flow cytometry method 0.0 0 cd3+ spleen 107732 3096
WAG/Nov plasma total cholesterol level control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. blood cholesterol amount male 150 days-180 days 10 79.5 mg/dl 3.8 12.02 plasma total cholesterol measurement test 0.0 0 107780 3096
WAG/Nov diastolic blood pressure control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. arterial blood pressure trait male 150 days-180 days 10 82.0 mmHg 7.4 23.4 unspecified method 0.0 0 107672 3096
WAG/Nov plasma corticosterone level control condition Redina OE, et al., Clin Exp Hypertens. 2010;32(6):364-71. doi: 10.3109/10641961003628502. blood corticosterone amount male 180 days 13 14.0 ng/ml 3.0 10.82 radioimmunoassay 0.0 0 97062 1818
WAG/Nov apoptotic hypodiploid thymocyte count to total thymocyte count ratio control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. T cell development trait male 150 days-180 days 10 0.34 % 0.09 0.28 flow cytometry method 0.0 0 107705 3096
WAG/Nov G2/M stage tetraploid thymocyte count to total thymocyte count ratio control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. T cell development trait male 150 days-180 days 10 3.13 % 0.46 1.45 flow cytometry method 0.0 0 107711 3096
WAG/Nov CD3+ thymocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 889.52 x10E6/organ 215.59 681.76 flow cytometry method 0.0 0 cd3+ thymocyte 107714 3096
WAG/Nov CD4+CD25+ thymocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 39.38 x10E6/organ 6.0 18.97 flow cytometry method 0.0 0 cd4+cd25+ t-cell 107726 3096
WAG/Nov systolic blood pressure control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. arterial blood pressure trait male 150 days-180 days 10 125.0 mmHg 10.2 32.26 unspecified method 0.0 0 107670 3096
WAG/Nov litter size control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. single birth offspring quantity female 98 days-112 days 5 7.6 null 0.7 1.57 in vivo visual assessment 0.0 0 110670 3182
WAG/Nov body weight control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. body mass male 7 days 15 11.9 g 7.2 27.89 body weighing method 0.0 0 110672 3182
WAG/Nov body weight control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. body mass male 14 days 15 21.2 g 1.6 6.2 body weighing method 0.0 0 110674 3182
WAG/Nov body weight control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. body mass male 25 days 15 40.6 g 5.3 20.53 body weighing method 0.0 0 110676 3182
WAG/Nov gestation period length control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. gestation period duration female 98 days-112 days 5 22.3 d 0.4 0.89 unspecified method 0.0 0 110680 3182
WAG/Nov systolic blood pressure control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. arterial blood pressure trait male 84 days-98 days 6 134.58 mmHg 6.28 15.38 tail cuff volume pressure recording 0.0 0 110682 3182
WAG/Nov body weight control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. body mass male 84 days-98 days 6 282.1 g 13.71 33.58 body weighing method 0.0 0 110686 3182
WAG/Nov time to first head dip within an experimental apparatus control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. head movement trait male 84 days-98 days 6 5.23 s 3.06 7.5 elevated plus maze apparatus method 300.0 0 within elevated plus maze head dips latency 110718 3182
WAG/Nov number of stretched-attend posture movements control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. stationary movement trait male 84 days-98 days 6 10.5 null 3.02 7.4 elevated plus maze apparatus method 300.0 0 110720 3182
WAG/Nov spleen cell count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. spleen morphology trait male 150 days-180 days 10 582.17 x10E6/organ 139.01 439.59 isolated cell counting method 0.0 0 107699 3096
WAG/Nov plasma corticosterone level control condition Cherkasova OP, Bull Exp Biol Med. 2006 Jan;141(1):30-2. doi: 10.1007/s10517-006-0085-4. blood corticosterone amount male 150 days-180 days 6 66.0 ng/ml 6.12 15.0 plasma corticosterone analysis 0.0 0 plasma corticosterone analysis (MMO:0000745) 107652 3087
WAG/Nov amount of time spent making head dipping movements in an experimental apparatus control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. head movement trait male 84 days-98 days 6 2.62 s 1.76 4.31 elevated plus maze apparatus method 300.0 0 within elevated plus maze head dips duration 110716 3182
WAG/Nov diastolic blood pressure control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. arterial blood pressure trait male 84 days-98 days 6 88.92 mmHg 4.73 11.59 tail cuff volume pressure recording 0.0 0 110684 3182
WAG/Nov amount of time spent exploring a novel object in an experimental apparatus control condition Ragaeva DS, et al., Physiol Behav. 2017 Jun 1;175:22-30. doi: 10.1016/j.physbeh.2017.03.026. Epub 2017 Mar 21. exploratory behavior trait male 84 days-98 days 6 30.07 s 4.47 10.95 open field apparatus method 300.0 0 NOR test; possibly three-chamber assay (MMO:0000604) novel object exploration duration 110726 3182